Yimitasvir

DB18768InvestigationalSmall molecule

Yimitasvir: Overview.

Mechanism: Pharmacologically active on Nonstructural protein 5A
Curator reviewed
Formula / weight: C₄₉H₅₈N₈O₆ · 855.053 g/mol (avg)
Code names: DAG-181

Resolves to

Compound

Structure

COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C2=C1[C@@H]1CC[C@H]2C1)C1=CC=C2N=C(NC2=C1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C

Targets

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Yimitasvir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.